Production (Stage)
Elite Pharmaceuticals, Inc.
ELTP
$0.517
-$0.0022-0.42%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.44% | -13.21% | 13.65% | 18.31% | 22.18% |
| Total Receivables | 58.27% | -13.94% | 4.67% | 5.31% | 21.51% |
| Inventory | -19.43% | 42.31% | 2.41% | 6.97% | -9.73% |
| Prepaid Expenses | -14.70% | 777.84% | -70.07% | -16.88% | -47.87% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 20.17% | 6.08% | 4.94% | 7.86% | 7.69% |
|
|
|||||
| Total Current Assets | 20.17% | 6.08% | 4.94% | 7.86% | 7.69% |
| Net Property, Plant & Equipment | 1.68% | -2.88% | -3.34% | 1.09% | 38.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -15.03% | 0.75% | -4.35% | 3.09% | 7.56% |
| Total Assets | 6.20% | 2.90% | 0.40% | 5.01% | 11.99% |
|
|
|||||
| Total Accounts Payable | -49.36% | 194.48% | -23.92% | -3.95% | -6.10% |
| Total Accrued Expenses | 7.52% | -39.18% | -4.46% | 14.80% | -59.47% |
| Short-term Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.44% | -2.96% | -0.98% | 14.29% | 175.71% |
| Total Finance Division Other Current Liabilities | -32.75% | 18.86% | -39.21% | 42.85% | 3,649.62% |
| Total Other Current Liabilities | -32.75% | 18.86% | -39.21% | 42.85% | 3,649.62% |
| Total Current Liabilities | -19.39% | 14.28% | -8.28% | 7.39% | -31.89% |
|
|
|||||
| Total Current Liabilities | -19.39% | 14.28% | -8.28% | 7.39% | -31.89% |
| Long-Term Debt | -0.63% | -0.77% | -5.19% | -1.07% | -1.12% |
| Short-term Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Capital Leases | -6.82% | -5.08% | -2.68% | -5.38% | 1,611.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -24.92% | 53.72% | 140.40% | 44.09% | 12.44% |
| Total Liabilities | -21.06% | 32.69% | 38.30% | 13.52% | -7.82% |
|
|
|||||
| Common Stock & APIC | 0.04% | 0.04% | 0.03% | 0.03% | 4.71% |
| Retained Earnings | 12.34% | -8.59% | -9.53% | 0.53% | 2.78% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 46.83% | -22.89% | -18.86% | 1.16% | 24.06% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 46.83% | -22.89% | -18.86% | 1.16% | 24.06% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 46.83% | -22.89% | -18.86% | 1.16% | 24.06% |
|
|
|||||